Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums so far in the field.
Antidepressants are the most prescribed therapy for depression. The exact mechanism of action of antidepressants is unknown. The theory is that antidepressants increase the concentration of one or more brain neurotransmitters which nerves in the brain use to communicate with one another. Neurotransmitters affected by antidepressants are serotonin, norepinephrine, and dopamine. The different classes of antidepressants differ in the neurotransmitters they affect. This determines some of their side effects and potential drug interactions. Mainly all available antidepressants are effective, and for most cases of depression there is no good evidence that any antidepressant is more effective than another.
OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that OMICS Group hosts over 700 edge peer reviewed Open Access Journals which contains over 75000 eminent personalities, reputed scientists as editorial board members. Omics International organizes over more than 1000 Global Events annually with support from 1000 more scientific Societies. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board that ensure a quality and quick review process checker.
Scope and Importance:
According to the doctors, antidepressants are a popular treatment choice for those with moderate or severe depression. It is a well-known fact that antidepressants may not cure depression but they can reduce your symptoms. It should be noted that the first antidepressant you try may work fine. In case if it fails to relieve your symptoms or bother you by causing numerous side-effects, there is a possibility that you may need to try another. You don’t have to give up after failure in the first attempt. Since a large number of antidepressants are available, there is always a chance that you'll be able to find one that works well for you.
It should be noted that there are a number of antidepressants available that work in slightly different ways and have different side effects. Choosing the right one generally involves subtle differences as most work equally well to relieve depression. Particular symptoms in an individual - It should be noted that symptoms of depression can vary from individual to individual. Also one antidepressant may relieve certain symptoms better than another. In case if your depression symptoms include low energy the best choice will be slightly stimulating antidepressants.
Side effects – It should be noted that side effects of antidepressants vary from one medication to another and from person to person. However bothersome side effects can make it difficult to stick with treatment. It has been estimated that sexual side effects are a particularly common reason people stop taking an antidepressant.
List of Best International Conferences
List of Related Societies
List of Related Companies
The major role played in the antidepressant market are Eli Lilly, Wyeth, Forest Laboratories, Pfizer, GlaxoSmithKline and Schering-Plough. Effexor holds the largest market share in the antidepressants market, at 36% ($3.93 billion), while Cymbalta grew the fastest, with sales jumping by 29% from $2.1 billion in 2007 to $2.7 billion in 2008.
This page will be updated regularly.
This page was last updated on November 22, 2024
